Telomir Pharmaceuticals, Inc. Share Price
NASDAQ: TELO | Micro Cap$0.97
+$0.97 (--%) Last updated on 30 Oct, 2026 | 01:11 ISTTelomir Pharmaceuticals, Inc. Stock Performance
Telomir Pharmaceuticals, Inc. Share Price Chart
$0.96$0.96
L
H
Telomir Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Telomir Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.
Telomir Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.17 | $0.96 | -18.22% |
Sep 2026 | $1.18 | $1.18 | +0.00% |
Aug 2026 | $1.22 | $1.18 | -3.28% |
Jul 2026 | $1.29 | $1.22 | -3.94% |
Jun 2026 | $1.24 | $1.27 | -1.93% |
May 2026 | $1.41 | $1.29 | -8.16% |
Apr 2026 | $1.25 | $1.41 | +10.16% |
Mar 2026 | $1.20 | $1.28 | -3.03% |
Feb 2026 | $1.17 | $1.32 | +14.78% |
Jan 2026 | $1.32 | $1.15 | -13.53% |
Dec 2025 | $1.31 | $1.33 | -0.75% |
Nov 2025 | $1.50 | $1.34 | -13.83% |